Viridian Therapeutics (VRDN) Stock Price & Financial Analysis
Viridian Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Viridian Therapeutics
What is the current stock price for VRDN?
As of the latest trading session, VRDN stock trades at $18.84. The 52-week range is $9.90–$34.29, with a day range of $18.44–$19.25.
What is the P/E ratio for VRDN?
The P/E ratio (Price-to-Earnings) for VRDN is shown in the Key Statistics section. This valuation metric helps compare Viridian Therapeutics, Inc. to industry peers.
Does VRDN pay dividends?
Viridian Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRDN?
Based on 9 analysts, the consensus for VRDN is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of VRDN?
Viridian Therapeutics's market capitalization is $1.60B, classifying it as a small-cap company. Viridian Therapeutics operates in the Healthcare sector within the Biotechnology industry.